Expert InsightsThe right drug targets for the right patient: Using biomarkers to solve challenges in drug development
Industry NewsSygnature Discovery acquires Peak Proteins to strengthen its drug discovery capabilities
Editorial ArticleConsistency is key: Developing recombinant antibodies for more reliable COVID-19 research
Industry NewsCytokine signature that allows COVID-19 patients with worst prognosis to be spotted early is identified by Italian researchers
Editorial ArticleFind the latest news from the 32nd European Congress of Clinical Microbiology & Infectious Diseases on SelectScience
Expert InsightsEvaluating oncology drugs in patient tumors with preserved native tumor microenvironment